1200.71.1003 Boehringer Ingelheim Investigational Site

New Haven, Connecticut

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung

Studies at this site

• Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer — Completed